Telix
Manufacturing · Australia · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
L 4 55 Flemington Rd, North Melbourne, V...Phone Number
+61390933855Website
www.telixpharma.comRevenue
$624.4 MillionStock Symbol
TLXIndustry
About Telix
Telix Pharmaceuticals is a global, commercial-stage biopharmaceutical company headquartered in North Melbourne, Australia, publicly listed on the Australian Securities Exchange and Nasdaq under the ticker TLX. The company specializes in the development and commercialization of diagnostic and therapeutic radiopharmaceuticals, commonly referred to as theranostics, which use molecularly targeted radiation to both image and treat cancer. Telix's pipeline is focused on urologic oncology (prostate and kidney), neuro-oncology (glioma), musculoskeletal oncology (sarcoma), and bone marrow conditioning. Its lead commercial product, Illuccix, is an approved PSMA-PET/CT imaging agent for prostate cancer with regulatory clearance from the FDA, Australia's TGA, and Health Canada.Explore more
SIC Code 28,283NAICS Code 32,325Ticker ASX: TLXShow moreTelix Org Chart
Compare Similar Companies to Telix
Compare insights from companies similar to Telix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Telix Tech Stack
A closer look at the technologies used by Telix
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Telix
Sign Up For FreeTo access detailed company insights
Telix Pharmaceuticals is a global, commercial-stage biopharmaceutical company headquartered in North Melbourne, Australia, publicly listed on the Australian Securities Exchange and Nasdaq under the ticker TLX. The company specializes in the development and commercialization of diagnostic and therapeutic radiopharmaceuticals, commonly referred to as... Read More
